Tuesday, December 11, 2012

Unhealthy result of popular weight loss drug

URI Pharmacy Professor Bingfang Yan’s recent study sounded a wake-up call to patients and doctors about the use of the most popular weight-loss drug therapies. Funded by the National Institutes of Health, his study found that the weight-loss drug orlistat, known by the brand names Xenical and Alli, inhibits a key enzyme that may lead to "severe toxicity of internal organs such as the liver and kidney." His findings received international attention, including coverage by Forbes, Science Daily, local outlets and informational calls from NBC news and the BBC. Read the original news release.